NeuroOne Medical Technologies
NMTC
11 hedge funds and large institutions have $686K invested in NeuroOne Medical Technologies in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
74% more capital invested
Capital invested by funds: $394K → $686K (+$292K)
10% more funds holding
Funds holding: 10 → 11 (+1)
0.07% less ownership
Funds ownership: 0.49% → 0.42% (-0.07%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$104K |
| 2 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$79.2K |
| 3 |
State Street
Boston,
Massachusetts
|
+$56.9K |
| 4 |
Jane Street
New York
|
+$32.1K |
| 5 |
NCG
Newport Capital Group
Red Bank,
New Jersey
|
+$29.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$248K |
| 2 |
KCIA
Kingsbury Capital Investment Advisors
Wilmette,
Illinois
|
-$44K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $193K | +$104K | +10,975 | +135% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $141K | -$248K | -26,079 | -65% |
|
|
DWM
3
Drive Wealth Management
Lehi,
Utah
| $113K | – | – | – |
|
|
MCM
4
MAI Capital Management
Independence,
Ohio
| $85K | +$79.2K | +8,333 | New |
|
|
5
State Street
Boston,
Massachusetts
| $61K | +$56.9K | +5,983 | New |
|
|
6
Jane Street
New York
| $34K | +$32.1K | +3,380 | New |
|
7
Northern Trust
Chicago,
Illinois
| $26K | – | – | – |
|
|
NCG
8
Newport Capital Group
Red Bank,
New Jersey
| $24K | +$29.1K | +3,058 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $9K | +$67 | +7 | +0.8% |
|
|
KCIA
10
Kingsbury Capital Investment Advisors
Wilmette,
Illinois
| – | -$44K | -8,901 | Closed |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$1K | -147 | Closed |
|
12
Wells Fargo
San Francisco,
California
| – | +$19 | +2 | +13% |
|
NMTC Hedge Fund Activity: Q3 2022 in Review
11 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q3 2022, worth a combined $686K — up 74% from $394K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NMTC positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $104K. The largest seller was Vanguard Group, cutting an estimated $248K.
- 11 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q3 2022, up from 10 in Q2 2022.
- Funds reported $686K of NeuroOne Medical Technologies stock for Q3 2022, up 74% quarter-over-quarter.
- 4 funds opened new NeuroOne Medical Technologies positions in Q3 2022 and 2 closed out, a net change of +2 holders.
- The largest NeuroOne Medical Technologies buyer in Q3 2022 was Geode Capital Management, an estimated $104K added.
- The largest NeuroOne Medical Technologies seller in Q3 2022 was Vanguard Group, an estimated $248K sold.
Based on aggregated 13F filings for Q3 2022.